NCT01466465View on ClinicalTrials.gov

Vitamin D and Grass Pollen Specific Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Allergic Rhinoconjunctivitis
Interventions
DRUG

Cholecalciferol

given orally, once daily, before grass pollen season

OTHER

middle-chain fatty acids (carrier)

given orally, once daily, before grass pollen season

Trial Locations (1)

10117

Charité Universitätsmedizin Berlin, Allergy-Centre-Charité, CCM, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT01466465 - Vitamin D and Grass Pollen Specific Immunotherapy | Biotech Hunter | Biotech Hunter